Application of Real-World Evidence in the Conditional Payment of High-Value Innovative Drugs ——A Case Study of the UK Cancer Drugs Fund and Innovative Medicines Fund
吕兰婷, 王知
China Health Insurance . 2026, (2): 42 -46 .  DOI: 10.19546/j.issn.1674-3830.2026.2.005

Copyright © China Health Insurance, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.